[ CAS No. 153034-90-3 ]

Name: 153034-90-3|2-Chloro-4-iodonicotinaldehyde|98%
Brand: Ambeed
SKU: A295519
Price: 6.0 USD
Availability: InStock
Rating: 90 (32 reviews)

{[proInfo.proName]} ,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

2D 3D

Structure of 153034-90-3 * Storage: {[proInfo.prStorage]}

Cart0 Bulk Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 88K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 153034-90-3 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 153034-90-3 ]

SDS

Alternatived Products of [ 153034-90-3 ]

Product Details of [ 153034-90-3 ]

CAS No. :	153034-90-3	MDL No. :	MFCD03095294
Formula :	C₆H₃ClINO	Boiling Point :	326.6°C at 760 mmHg
Linear Structure Formula :	-	InChI Key :	-
M.W :	267.45 g/mol	Pubchem ID :	10038637
Synonyms :

Safety of [ 153034-90-3 ]

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Application In Synthesis of [ 153034-90-3 ]

Upstream synthesis route of [ 153034-90-3 ]
Downstream synthetic route of [ 153034-90-3 ]

[ 153034-90-3 ] Synthesis Path-Upstream 1~6

1
[ 78607-36-0 ]
[ 109-94-4 ]
[ 153034-90-3 ]

Yield	Reaction Conditions	Operation in experiment
54%	Stage #1: With lithium diisopropyl amide In tetrahydrofuran at -78℃; for 3 h; Stage #2: at -78℃; for 1.5 h;	Example 1 :N-(2-(2,6-Dichlorophenyl)-2H-pyrazolo[4,3-c]pyridin-4-yl)cyclopropanecarboxamideStep 1 :2-Chloro-4-iodonicotinaldehydeA mixture of 2-chloro-3-iodopyridine (5.0 g, 21 mmol) in dry THF (30 mL) was slowly added to a cold (-78 °C) solution of lithium diisopropylamide (15 mL, 30 mmol) in dry THF (50 mL). The resulting mixture was stirred for 3 h at this temperature. Ethyl formate (4.0 g, 54 mmol) was then added. Stirring was continued for 1.5 h at the same temperature. Water (10 mL) was added to quench the reaction, and then the resulting mixture was warmed to room temperature. 2M HC1 (50 mL) was added and then the THF was removed under reduced pressure. The aqueous residue was extracted with ethyl acetate (2 x 50 mL). The combined organic extracts were washed with brine, dried over Na₂S0₄ and concentrated under reduced pressure. The residue was purified on silica gel (diethyl ether: petroleum ether = 1 : 4) to give the desired product 2-chloro- 4-iodonicotinaldehyde as a yellow solid (3.0 g, 54percent yield). NMR (500 MHz, CDC1₃): δ 10.22 (s, 1H), 8.09 (d, J = 5.0 Hz, 1H), 7.95 (d, J = 5.0 Hz, 1H).

Reference： [1] Synthetic Communications, 1996, vol. 26, # 23, p. 4421 - 4436
[2] Journal of Organic Chemistry, 1993, vol. 58, # 27, p. 7832 - 7838
[3] Journal of Heterocyclic Chemistry, 2001, vol. 38, # 5, p. 1039 - 1044
[4] Patent: WO2012/66061, 2012, A1, . Location in patent: Page/Page column 76-77

2
[ 153034-86-7 ]
[ 109-94-4 ]
[ 153034-90-3 ]

Yield	Reaction Conditions	Operation in experiment
54%	Stage #1: With lithium diisopropyl amide In tetrahydrofuran at -78℃; for 3 h; Stage #2: at -78℃; for 1.5 h;	A mixture of 2-chloro-3-iodopyridine(5.0g, 21mmol) in dry THF (30 mL) was slowly added to a cold (-78°C) solution oflithiumdiisopropylamide(15 mL, 30mmol) in dry THF (50 mL). The resulting mixture was stirred for 3h at this temperature.Ethylformate(4.0g, 54mmol) wasthenadded.Stirring continued for 1.5 h at the same temperature.Water (10 mL) was added to quench the reaction, and then theresultingmixture was warmed toroom temperature.2 MHCl(50 mL) was added and then the THF was removed under reduced pressure.The aqueous residue was extracted withethyl acetate(2 x 50 mL).The combined organic extracts were washed with brine, dried over Na₂SO₄andconcentrated under reduced pressure.The residuewas purified on silica gel(diethyl ether/petroleum ether1:4)to give the desired product as a yellow solid(3.0 g, 54percent yield).HNMR(500 MHz, CDCl₃):δ10.22(s, 1H), 8.09(d, J =5.0Hz, 1H), 7.95(d,J =5.0Hz, 1H).
52%	Stage #1: With lithium diisopropyl amide In tetrahydrofuran at -78℃; for 3 h; Inert atmosphere; Schlenk technique Stage #2: at -78℃; for 1.5 h; Inert atmosphere; Schlenk technique	According to the literature,17 a dry, argon-flushed Schlenk flask equipped with a magnetic stirring bar and a septum was charged with a solution of LDA (18.0 mmol, 1.0 M in THF) and cooled to –78 °C. 2-Chloro-3-iodopyridine (3.1 g, 13.0 mmol) was added dropwise tothe cooled solution. The resulting mixture was stirred for 3 h at –78 °C. Ethyl formate (2.5 g, 34.0 mmol) was then added and stirred for 1.5 hat –78 °C. The resulting solution was quenched with sat. aq NH4Cl (80 mL), extracted with EtOAc (3 × 120 mL), and the combined organic phases were dried (anhyd MgSO4). After filtration, the solvents were evaporated in vacuo. The crude product was purified by flash column chromatography on silica gel (i-hexane/EtOAc, 9:1 to 8:2 +Et3N 2percent) yielding 2-chloro-4-iodonicotinaldehyde as a yellow solid(1.8 g, 52percent). 1H NMR (400 MHz, CDCl3): δ = 10.19 (s, 1 H), 8.07 (d, J = 5.1 Hz, 1 H),7.94 (d, J = 5.1 Hz, 1 H).

Reference： [1] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 18, p. 4370 - 4376
[2] Synthesis (Germany), 2018, vol. 50, # 1, p. 155 - 169
[3] Organic Letters, 2018, vol. 20, # 2, p. 345 - 348

3
[ 153034-90-3 ]
[ 688357-19-9 ]

Reference： [1] Patent: WO2013/9582, 2013, A1,
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 13, p. 5800 - 5816

4
[ 153034-90-3 ]
[ 871836-51-0 ]

Yield	Reaction Conditions	Operation in experiment
70%	With hydrazine hydrate In ethanol at 0 - 20℃;	To a solution of 2-chloro-4-iodonicotinaldehyde (101) (1.33 g, 5 mmol) in EtOH (10 mL), N₂H₄H₂O (480 uL, 2 eq, 10 mmol) was added slowly at 0 - 5 °C. The solution was stirred at 10 °C for 1 h. Then additional amount of N₂H₄H₂O (480 uL, 2 eq, 10 mmol) was added slowly and the resulting mixture was stirred at RT overnight. The mixture was concentrated in vacuo, brine (20 mL) was added and then extracted with ethyl acetate (3 * 50 mL). The combined organic layer was washed with brine (20 mL), dried over MgSO₄ and filtered. The filtrate was concentrated in vacuo to afford the crude product.
19%	With hydrazine In ethanol at 20℃; for 15 h;	Step 2:4-Chloro-lH-pyrazolo[4,3-c]pyridine To a mixture of 2-chloro-4-iodonicotinaldehyde (1.0 g, 3.7 mmol) in ethanol (6.0 mL) was added 3.0 mL of hydrazine (excess). The mixture was stirred at room temperature for 15 h and then concentrated under reduced pressure. The residue was diluted with water (30 mL) and extracted with dichloromethane (300 mL). The organic extract was washed with brine, dried over Na₂S0₄, and concentrated under reduced pressure. The residue was dissolved in dichloromethane (5 mL) and stirred for 5 min. The precipitated solid was isolated by filtration and dried to give the desired intermediate 4-chloro-lH-pyrazolo[4,3-c]pyridine as a grey solid (110 mg, 19percent yield), which was used in the next step without further purification. LCMS(ESI) m/z: 154.1 [M+H⁺]

Reference： [1] Patent: EP2252293, 2018, B1, . Location in patent: Paragraph 0257; 0258
[2] Patent: WO2012/66061, 2012, A1, . Location in patent: Page/Page column 77
[3] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 18, p. 4370 - 4376

5
[ 153034-90-3 ]
[ 1186647-69-7 ]

Reference： [1] Patent: EP2252293, 2018, B1,

6
[ 153034-90-3 ]
[ 1171919-75-7 ]

Reference： [1] Patent: US2010/298334, 2010, A1, . Location in patent: Page/Page column 97

[ 153034-90-3 ] Synthesis Path-Downstream 1~16

1
[ 916203-67-3 ]
[ 153034-90-3 ]
(2E)-3-(2-chloro-4-iodopyridin-3-yl)-N-(2,6-dichlorophenyl)acrylamide [ No CAS ]

Reference： [1]Journal of Organic Chemistry,2006,vol. 71,p. 8610 - 8613

2
[ 1160502-08-8 ]
[ 153034-90-3 ]
[ 1160502-09-9 ]

Yield	Reaction Conditions	Operation in experiment
74%	With copper(l) iodide; potassium carbonate; tris-(o-tolyl)phosphine;palladium diacetate; In tetrahydrofuran; for 1.25h;Heating / reflux;	A suspension of <strong>[153034-90-3]2-chloro-4-iodonicotinaldehyde</strong> (90.3 mg, 0.338 mmol)(prepared via J. Org. Chem., 1993, 58, 7832), 2-methyl-2-(6-(6-phenyl-l, 3,6,2- dioxazaborocan-2-yl)pyridin-2-yl)propanenitrile (226 mg, 0.675 mmol), tri-o- tolylphosphine (21 mg, 0.068 mmol), palladium acetate (5 mol %, 3.8 mg, 0.017 mmol), potassium carbonate (93 mg, 0.675 mmol) and copper(I) iodide (26 mg, 0.135 mmol) in tetrahydrofuran (5 ml) was heated at reflux under nitrogen for 75 minutes. The mixture was cooled down to room temperature, filtered through a path of celite and evaporated to dryness. The residue was purified on silica gel by flash column chromatography to afford the title compound as an off-white solid (71 mg, 74% yield).1H NMR (CDCl3, 400 MHz) delta 1.76 (6H, s), 7.58 (IH, d), 7.70 (IH, d), 7.72 (IH, d), 7.95 (IH, t), 8.60 (IH, d), 10.39 (IH, s).

Reference： [1]Patent: WO2009/73300,2009,A1 .Location in patent: Page/Page column 106

3
[ 1161719-82-9 ]
[ 153034-90-3 ]
C₁₉H₁₇BrClIN₂O₂ [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry,2009,vol. 17,p. 3308 - 3316

4
[ 623-51-8 ]
[ 153034-90-3 ]
ethyl 4-iodothieno[2,3-b]pyridine-2-carboxylate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
46%		EXAMPLE 6 : 2-ethyl-iV-phenethylthieno[2,3-b]pyridin-4-ainine (Final Compound 96) a) ethyl 4-iodothieno[2,3-b]pyridine-2-carboxylate; According to Scheme 1 Step 1 and 2: A mixture of <strong>[153034-90-3]2-chloro-3-formyl-4-iodopyridine</strong> (1.0Og, 3.74mmol) and potassium carbonate (0.568g, 4.11mmol) in DMF (8ml) was heated at 80C. Then ethyl-2-mercaptoacetate (0.396ml, 3.59mmol) was added drop wise at 80C for 2 hours. Then, the mixture was heated at that temperature for 19 hours, poured onto water (200ml) and extracted with ethyl acetate. The organic layer was dried over MgSO4, filtered, and evaporated till dryness. The residue (1.25g), was purified by chromatography (Cl 8, Flashmart Pack: 65g/60-40um, eluent ACN/water 60:40) yielding title compound (0.415g, 46%) as white solid.

Reference： [1]Patent: WO2006/30031,2006,A1 .Location in patent: Page/Page column 54

5
[ 936939-28-5 ]
[ 153034-90-3 ]
2-(2-chloro-4-iodo-pyridin-3-yl)-6-(7-ethyl-2,7-diaza-spiro[4,4]non-2-yl)-4-methyl-1H-benzoimidazole [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
86%		2-(2-Chloro-4-iodo-pyridin-3-yl)-6-(7-ethyl-2,7-diaza-spiro[4.4]non-2-yl)-4-methyl-lH-benzoimidazole; To a solution of 4-(7-ethyl-2,7-diaza-spiro[4.4]non-2-yl)-2- methyl-6-nitro-phenylamine (304 mg, 1.0 mmol) in MeOH (47.5 mL) were added Pd/C (10%, 40 mg) and acetic acid (2.5 mL). The mixture was stirred under atmospheric hydrogen (balloon) at the room temperature for 3 h and then filter over Celite. The filtrate was mixed with <strong>[153034-90-3]2-chloro-3-formyl-4-iodopyridine</strong> (267.5 mg, 1.0 mmol), stirred at the room temperature for 18 h, and evaporated to dryness under reduced pressure. The residue was dissolved in MeOH (10 mL) and 28% aqueous NH4OH solution (0.5 mL) was added. After it was stirred for 5 min, the mixture was concentrated and chromatographyed (5:1, CH2Cl2/Me0H) to afford the title compound (450 mg, 86 %). 1H NMR (MeOH-J4) delta 1.38 (t, J= 8 Hz, 3H)5 2.10-2.21 (4H), 2.56 (s, 3H), 3.28-3.57 (10H), 6.55 (s, IH), 6.57 (s, IH), 8.03 (d, J= 6 Hz, IH), 8.13 (d, J= 6 Hz, IH). ESI-MS mlz 522 (MH+).

Reference： [1]Patent: WO2007/56155,2007,A1 .Location in patent: Page/Page column 238

6
[ 936939-29-6 ]
[ 153034-90-3 ]
2-benzyl-8-[2-(2-chloro-4-iodo-pyridin-3-yl)-7-methyl-3H-benzoimidazol-5-yl]-2,8-diaza-spiro[5.5]undecane [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
9%		2-Benzyl-8-[2-(2-chloro-4-iodo-pyridin-3-yl)-7-methyl-3H-benzoimidazol-5-yl]-2,8-diaza-spiro[5.5]undecane; To a solution of 4-(8-benzyl-2,8-diaza-spiro[5.5]undec- 2-yl)-2-methyl-6-nitro-phenylamine (394 mg, 1.0 mmol) in MeOH (47.5 mL) were added Pd/C (10%, 40 mg) and acetic acid (2.5 mL). The mixture was stirred under atmospheric hydrogen (balloon) at the room temperature for 3 h and filter over Celite. The filtrate was mixed with <strong>[153034-90-3]2-chloro-3-formyl-4-iodopyridine</strong> (267.5 mg, 1.0 mmol), stirred at the room temperature for 18 h, and evaporated to dryness under reduced pressure. The residue was dissolved in MeOH (10 mL) and 28% aqueous NH4OH solution (0.5 mL) was added. After it was stirred for 5 min, the mixt chromatographyed (330:10:1 CH2Cl2 <n="241"/>/MeOH/28% aqueous NH4OH) to afford the title compound (55 mg, 9%). 1H NMR (CDCl3) delta 1.22-1.36 (2H)3 1.49-1.84 (6H), 1.95-2.59 (6H), 2.59 (s, 3H), 2.94-3.45 (6H), 6.82 (s, IH), 6.87 (s, IH), 7.16-7.33 (5H)5 7.72 (d, J= 6 Hz, IH), 7.99 (d, J= 6 Hz, IH). ESI-MS m/z 612 (MH+).

Reference： [1]Patent: WO2007/56155,2007,A1 .Location in patent: Page/Page column 238-239

7
[ 936939-29-6 ]
[ 153034-90-3 ]
2-[2-(2-chloro-4-iodo-pyridin-3-yl)-7-methyl-3H-benzoimidazol-5-yl]-2,8-diaza-spiro[5.5]undecane [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
55%		2-Benzyl-8-[2-(2-chloro-4-iodo-pyridin-3-yl)-7-methyl-3H-benzoimidazol-5-yl]-2,8-diaza-spiro[5.5]undecane; To a solution of 4-(8-benzyl-2,8-diaza-spiro[5.5]undec- 2-yl)-2-methyl-6-nitro-phenylamine (394 mg, 1.0 mmol) in MeOH (47.5 mL) were added Pd/C (10%, 40 mg) and acetic acid (2.5 mL). The mixture was stirred under atmospheric hydrogen (balloon) at the room temperature for 3 h and filter over Celite. The filtrate was mixed with <strong>[153034-90-3]2-chloro-3-formyl-4-iodopyridine</strong> (267.5 mg, 1.0 mmol), stirred at the room temperature for 18 h, and evaporated to dryness under reduced pressure. The residue was dissolved in MeOH (10 mL) and 28% aqueous NH4OH solution (0.5 mL) was added. After it was stirred for 5 min, the mixt chromatographyed (330:10:1 CH2Cl2 <n="241"/>/MeOH/28% aqueous NH4OH) to afford the title compound (55 mg, 9%). 1H NMR (CDCl3) delta 1.22-1.36 (2H)3 1.49-1.84 (6H), 1.95-2.59 (6H), 2.59 (s, 3H), 2.94-3.45 (6H), 6.82 (s, IH), 6.87 (s, IH), 7.16-7.33 (5H)5 7.72 (d, J= 6 Hz, IH), 7.99 (d, J= 6 Hz, IH). ESI-MS m/z 612 (MH+).

Reference： [1]Patent: WO2007/56155,2007,A1 .Location in patent: Page/Page column 238-239

8
[ 153034-90-3 ]
[ 1171919-75-7 ]

Yield	Reaction Conditions	Operation in experiment
	With ammonium hydroxide; iodine; In tetrahydrofuran; at 20℃;	Step 1. 2-chloro-4-iodonicotinonitrileTo <strong>[153034-90-3]2-chloro-4-iodonicotinaldehyde</strong> (1.0 g, 3.7 mmol) dissolved in THF (11 mL) was added ammonium hydroxide (11 mL, 280 mmol) followed by iodine (1040 mg, 4.11 mmol), the reaction was held at ambient temperature 3.5 h, color visibly lightens as reaction progresses until the end when it is nearly colorless. LCMS indicates reaction to be complete. Reaction was quenched by addition of saturated NaHSO3, extracted into EtOAc. The organic phase was washed with brine, dried over MgSO4, filtered and concentrated in vacuo to provide the crude product, 926 mg. Dissolved in CHCl3/MeOH and applied to 120 g silica gel column, the product fractions were concentrated in vacuo to give 728 mg product. The purified material was taken directly to next step.

Reference： [1]Patent: US2010/298334,2010,A1 .Location in patent: Page/Page column 97

9
[ 153034-90-3 ]
[ 1257072-10-8 ]

Reference： [1]Patent: US2010/298334,2010,A1

10
[ 153034-90-3 ]
[ 1257072-23-3 ]

Reference： [1]Patent: US2010/298334,2010,A1

11
[ 153034-90-3 ]
[ 871836-51-0 ]

Yield	Reaction Conditions	Operation in experiment
70%	With hydrazine hydrate; In ethanol; at 0 - 20℃;	To a solution of <strong>[153034-90-3]2-chloro-4-iodonicotinaldehyde</strong> (101) (1.33 g, 5 mmol) in EtOH (10 mL), N2H4H2O (480 uL, 2 eq, 10 mmol) was added slowly at 0 - 5 °C. The solution was stirred at 10 °C for 1 h. Then additional amount of N2H4H2O (480 uL, 2 eq, 10 mmol) was added slowly and the resulting mixture was stirred at RT overnight. The mixture was concentrated in vacuo, brine (20 mL) was added and then extracted with ethyl acetate (3 * 50 mL). The combined organic layer was washed with brine (20 mL), dried over MgSO4 and filtered. The filtrate was concentrated in vacuo to afford the crude product.
19%	With hydrazine; In ethanol; at 20℃; for 15h;	Step 2:4-Chloro-lH-pyrazolo[4,3-c]pyridine To a mixture of <strong>[153034-90-3]2-chloro-4-iodonicotinaldehyde</strong> (1.0 g, 3.7 mmol) in ethanol (6.0 mL) was added 3.0 mL of hydrazine (excess). The mixture was stirred at room temperature for 15 h and then concentrated under reduced pressure. The residue was diluted with water (30 mL) and extracted with dichloromethane (300 mL). The organic extract was washed with brine, dried over Na2S04, and concentrated under reduced pressure. The residue was dissolved in dichloromethane (5 mL) and stirred for 5 min. The precipitated solid was isolated by filtration and dried to give the desired intermediate 4-chloro-lH-pyrazolo[4,3-c]pyridine as a grey solid (110 mg, 19percent yield), which was used in the next step without further purification. LCMS(ESI) m/z: 154.1 [M+H+]
	With hydrazine; In ethanol; at 20℃; for 15h;	To a mixture of <strong>[153034-90-3]2-chloro-4-iodonicotinaldehyde</strong>(1.0g, 3.7mmol) in ethanol(6.0 mL)was added 3.0mL of hydrazine (excess).The mixture was stirred atroom temperaturefor 15h and then concentrated under reduced pressure.The residue was diluted with water (30 mL)and extracted with dichloromethane (300 mL).The organic extract was washed with brine, dried over Na2SO4, and concentrated under reduced pressure.The residue was dissolved indichloromethane (5 mL)and stirred for 5 min. The precipitated solid was isolated by filtration and dried to give the desiredproductas a grey solid(110 mg, 19percent yield), which was used in the next step without further purification.LCMS(ESI) m/z: 154.1[M+H+].

Reference： [1]Patent: EP2252293,2018,B1 .Location in patent: Paragraph 0257; 0258
[2]Patent: WO2012/66061,2012,A1 .Location in patent: Page/Page column 77
[3]Bioorganic and Medicinal Chemistry Letters,2017,vol. 27,p. 4370 - 4376

12
[ 153034-90-3 ]
[ 1378039-21-4 ]
[ 1378039-20-3 ]

Reference： [1]Patent: WO2012/66061,2012,A1
[2]Bioorganic and Medicinal Chemistry Letters,2017,vol. 27,p. 4370 - 4376

13
[ 153034-90-3 ]
[ 1378037-55-8 ]

Reference： [1]Patent: WO2012/66061,2012,A1
[2]Bioorganic and Medicinal Chemistry Letters,2017,vol. 27,p. 4370 - 4376

14
[ 153034-90-3 ]
[ 1378037-56-9 ]

Reference： [1]Patent: WO2012/66061,2012,A1

15
[ 153034-90-3 ]
[ 1378038-47-1 ]

Reference： [1]Patent: WO2012/66061,2012,A1

16
[ 153034-90-3 ]
[ 1378038-48-2 ]

Reference： [1]Patent: WO2012/66061,2012,A1

Related Products

Historical Records

Related Functional Groups of
[ 153034-90-3 ]

Chlorides

[ 153034-88-9 ]

2-Chloro-4-iodo-3-methylpyridine

Similarity: 0.85

[ 153034-86-7 ]

2-Chloro-4-iodopyridine

Similarity: 0.73

[ 59782-89-7 ]

2-Chloro-5-iodo-3-methylpyridine

Similarity: 0.71

[ 55676-21-6 ]

1-(2-Chloropyridin-3-yl)ethanone

Similarity: 0.71

[ 884494-50-2 ]

2-Chloro-5-fluoro-4-iodo-3-methylpyridine

Similarity: 0.71

Aldehydes

[ 851484-95-2 ]

2-Chloro-5-fluoronicotinaldehyde

Similarity: 0.67

[ 55304-73-9 ]

2,6-Dichloro-3-formylpyridine

Similarity: 0.67

[ 228251-24-9 ]

5-Bromo-2-chloronicotinaldehyde

Similarity: 0.66

[ 95652-80-5 ]

2-Chloro-6-methoxynicotinaldehyde

Similarity: 0.62

[ 73568-27-1 ]

2-Chloro-6-methylquinoline-3-carbaldehyde

Similarity: 0.62

Related Parent Nucleus of
[ 153034-90-3 ]

Pyridines

[ 153034-88-9 ]

2-Chloro-4-iodo-3-methylpyridine

Similarity: 0.85

[ 153034-86-7 ]

2-Chloro-4-iodopyridine

Similarity: 0.73

[ 59782-89-7 ]

2-Chloro-5-iodo-3-methylpyridine

Similarity: 0.71

[ 55676-21-6 ]

1-(2-Chloropyridin-3-yl)ethanone

Similarity: 0.71

[ 884494-50-2 ]

2-Chloro-5-fluoro-4-iodo-3-methylpyridine

Similarity: 0.71

Ghs Precautionary Statements

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Purity	Size	Price	VIP Price	USA Stock *0-1 Day	Global Stock *5-7 Days	Quantity
{[ item.p_purity ]}	{[ item.pr_size ]}	{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]}	{[ getRatePrice(item.pr_usd, 1,1) ]}	{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]}	{[ item.pr_usastock ]}	Inquiry -	{[ item.pr_chinastock ]}	Inquiry -

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere

[ CAS No. 153034-90-3 ]

Quality Control of [ 153034-90-3 ]

Related Doc. of [ 153034-90-3 ]

Product Details of [ 153034-90-3 ]

Safety of [ 153034-90-3 ]

Application In Synthesis of [ 153034-90-3 ]

[ 153034-90-3 ] Synthesis Path-Upstream 1~6

[ 153034-90-3 ] Synthesis Path-Downstream 1~16

Related Functional Groups of [ 153034-90-3 ]

Chlorides

Aldehydes

Related Parent Nucleus of [ 153034-90-3 ]

Pyridines

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Related Functional Groups of
[ 153034-90-3 ]

Related Parent Nucleus of
[ 153034-90-3 ]